Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators

European Journal of Medicinal Chemistry
2016.0

Abstract

Novel Y-shaped barbituric acid (BA) derivatives have been designed using rational methods including molecular docking. Fourteen novel compounds were synthesized using hydroxyl group protection-deprotection strategies for PPARγ activation. Competitive binding analysis of the synthesized molecules using time-resolved fluorescence resonance energy transfer (FRET) method was carried out, and the IC50 values were determined. The symmetrically substituted derivatives have shown greater binding affinity than unsymmetrically substituted derivatives. Nitrobenzyl and cyanophenyl substituted derivatives have shown reasonable binding affinities (10.1 and 6.5 μM, respectively), while mono and diacetate derivatives were found inactive. Molecular dynamics simulations show that the designed compounds have interaction profiles similar to partial agonists. The most significant finding of our study is that BA derivatives with symmetrically substituted weakly polar side chains result in the desired moderate level of PPARγ binding affinities.

Knowledge Graph

Similar Paper

Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators
European Journal of Medicinal Chemistry 2016.0
New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies
Bioorganic & Medicinal Chemistry Letters 2008.0
Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists
Bioorganic & Medicinal Chemistry 2012.0
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity
Bioorganic & Medicinal Chemistry 2008.0
New PPARγ ligands based on 2-hydroxy-1,4-naphthoquinone: Computer-aided design, synthesis, and receptor-binding studies
Bioorganic & Medicinal Chemistry Letters 2008.0
Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling
European Journal of Medicinal Chemistry 2008.0
Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety
Bioorganic & Medicinal Chemistry Letters 2007.0
Design, synthesis, and biological activity of novel PPARγ ligands based on rosiglitazone and 15d-PGJ2
Bioorganic & Medicinal Chemistry Letters 2005.0
Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives:  A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity
Journal of Medicinal Chemistry 2005.0
Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARγ activators
Bioorganic & Medicinal Chemistry Letters 2007.0